Is Cancer treatment the next promising application of mRNA technology?
SOPHIA ANTIPOLIS, France – October 10, 2022 │ Since 2020 and the COVID-19 crisis, mRNA technology has experienced a big boost in interest thanks to the outstanding results of vaccines produced by Moderna and Pfizer/BioNTech. Indeed, the threat of the COVID-19 pandemic accelerated rapid-response vaccine development. mRNA-based therapeutics were shown to deliver on their promise:[…]